$TDOC Teladoc reversal targets as Covid Rhetoric intensifies
Increased covid fears may help a recovery in TDOC after a 33% decline from the Aug high.
RSI seems to have bottomed.
Volume this week may be the capitulation needed to form a bottom.
Stock managed to close above the 200MA .
Possible day trade targets $190 & $193
dependent on NQ strength
0LDR trade ideas
$TDOC ATH Projection going into January 2021Based on Tsla fractal
Now $182, weekend following Biden as president elect, anti social stocks (ZM, TDOC) taking a hit from market's bullish outlook of Biden's presidency, while in person traffic stocks pump (amusement parks like $dis and $seas)
Prediction: Pfizer's vaccine and Biden's covid taskforce news are providing momentary relief and comfort that we're in proper hands to get out of this pandemic, which I believe is the cause for the dip in $TDOC. However, cases are still rising, and there is still a factor of the American population that will deny receiving the vaccine treatment based on conspiracies. Hospitals will be over flooded with patients, forcing this service to gain momentum in the coming months.
Looking to see $TDOC hit all time highs in January, well over $300.
Long term projection: $1k by 2022
Livongo (LVGO) to Teledoc(TDOC) Merger SuccessLivongo (LVGO) to Teledoc(TDOC) Merger Success
Quick focus before sleeping:
Outlook for the company is strong in a quarterly bases: www.fool.com
COVID-19 is still ramping havoc on the world; and, winter 2020 is about to come. It is November now.
This company is positions globally as well to take advantage of its market.
Conclusion:
continuation of fundamental and technical trend
currency price of TDOC: 200.98
tentative target: 500
Bottomed the trend and earnings tomorrow The earnings report tomorrow is anyones guess, but as covid has kept people home, I'm pretty bullish on it. The last earnings report missed the analysts estimated target by a considerable amount, although staying within trend, it has set the stock up fo a nice position for good gains ahead in my opinion.
I can see this type of industry expanding as society changes to the new norm
TDOC pitchfork pattern analysisTDOC closed below the 2nd pitchfork on 9/16 which is the signal the trend will soon reverse and go up. That happened indeed. At this point TDOC reached the top of the 1st pitchfork which acts as a resistance line (and is also close to the purple resistance line). This means it may bounce back down or break through. Given that that market has reversed and is going up (see my related SPY ideas below), it is likely that TDOC will break trough. Then I expect TDOC to reach the upper line of the last pitchfork (see the blue arrow). Given more time TDOC will likely reach at least the middle (brown) line of the second pitchfork.
Additionally, there is also an bullish signal on 9/10 for TDOC (when price was 198.14) for a strategy with 952% backtesting profit since 2016 (market data available since some time in 2015) and 77% profitable trades (the strategy is based on my Tug-of-War indicators).
Conclusion: go long. Post-market TDOC is down to 213.38 at this time. If that stays the same till tomorrow at opening it may be a good buy opportunity.
"Like it" if you like it! Add your comments, questions or concerns if you have any.
DISCLAIMER: Security trading involves substantial risk of loss. My analysis is not trading advice. Do your own research first and/or consult a financial advisor. I'm not responsible for any losses you may incur following my analysis.
$TDOC Downtrend Breakout - Unusual Bullish Options Flow$TDOC telehealth company Teladoc Health broke out of a recent downtrend today and closed above resistance.
There was also some unusual bullish options flow today with about $7M in near term calls traded. Specifically the $215 strike call expiring this week traded more than 10x its open interest just today. Put/Call Volume Ratio was about 4:1 or in other words for every put traded today four calls were traded.
A reliable breakout confirmation would be to see this pull back to the downtrend line (~$211.50) this week and retest it as support.
Near term price target: $228
Medium term price target: $250 (late October)
Also of note: a Bullish analyst note published today: "D.A. Davidson analyst Hannah Baade initiated coverage of Teladoc with a Buy rating and $250 price target."
See Benzinga Article: "Stay-At-Home Stock Play Teladoc Set For Q3 Beat, DA Davidson Says In Bullish Initiation"